Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152

Cancer Letters

Volumn 359, Issue 1, 2015, Pages 75-86

  Yao, Yilong ^a   Ma, Jun ^a   Xue, Yixue ^a   Wang, Ping ^a   Li, Zhen ^a   Liu, Jing ^a   Chen, Liangyu ^a   Xi, Zhuo ^a   Teng, Hao ^a   Wang, Zhenhua ^a   Li, Zhiqing ^a   Liu, Yunhui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Glioblastoma; Long non coding RNAs; MiR 152; Stem cells; XIST

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 152; UNCLASSIFIED DRUG; MIRN152 MICRORNA, HUMAN; RNA INDUCED SILENCING COMPLEX; XIST NON-CODING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CELL ISOLATION; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE REPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MIGRATION INHIBITION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; RNA BINDING; STEM CELL; SURVIVAL RATE; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION; X INACTIVE SPECIFIC TRANSCRIPT GENE; ANIMAL; BAGG ALBINO MOUSE; BRAIN NEOPLASMS; CANCER STEM CELL; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PROCEDURES; TIME; TUMOR CELL CULTURE; TUMOR VOLUME;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; GLIOBLASTOMA; HUMANS; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; RNA, LONG NONCODING; RNA-INDUCED SILENCING COMPLEX; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; TUMOR CELLS, CULTURED; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84922214097     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.12.051     Document Type: Article

References (49)

1. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007, 21:2683-2710.
2. Schwartzbaum J.A., Fisher J.L., Aldape K.D., Wrensch M. Epidemiology and molecular pathology of glioma. Nat. Clin. Pract. Neurol 2006, 2:494-503. quiz 491 p following 516.
3. Tanaka S., Louis D.N., Curry W.T., Batchelor T.T., Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?. Nat. Rev. Clin. Oncol 2013, 10:14-26.
4. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004, 64:7011-7021.
5. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
6. Mazzoleni S., Politi L.S., Pala M., Cominelli M., Franzin A., Sergi L., et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 2010, 70:7500-7513.
7. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
8. Rich J.N. Cancer stem cells in radiation resistance. Cancer Res 2007, 67:8980-8984.
9. Aldea M.D., Petrushev B., Soritau O., Tomuleasa C.I., Berindan-Neagoe I., Filip A.G., et al. Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells. J. BUON 2014, 19:502-511.
10. Cheng L., Bao S., Rich J.N. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem. Pharmacol 2010, 80:654-665.
11. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
12. Kapranov P., Willingham A.T., Gingeras T.R. Genome-wide transcription and the implications for genomic organization. Nat. Rev. Genet 2007, 8:413-423.
13. Lipovich L., Johnson R., Lin C.Y. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim. Biophys. Acta 2010, 1799:597-615.
14. Eades G., Zhang Y.S., Li Q.L., Xia J.X., Yao Y., Zhou Q. Long non-coding RNAs in stem cells and cancer. World J. Clin. Oncol 2014, 5:134-141.
15. Wang P., Ren Z., Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J. Cell. Biochem 2012, 113:1868-1874.
16. Ellis B.C., Molloy P.L., Graham L.D. CRNDE: a long non-coding RNA involved in CanceR, Neurobiology, and DEvelopment. Front. Genet 2012, 3:270.
17. Yao Y., Xue Y., Ma J., Shang C., Wang P., Liu L., et al. MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways. PLoS ONE 2014, 9. e95060.
18. Yao Y.L., Ma J., Wang P., Xue Y.X., Li Z., Zhao L.N., et al. miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells. CNS Neurosci. Ther 2015, 21:40-51.
19. Kallen A.N., Zhou X.B., Xu J., Qiao C., Ma J., Yan L., et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 2013, 52:101-112.
20. Brown C.J., Ballabio A., Rupert J.L., Lafreniere R.G., Grompe M., Tonlorenzi R., et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991, 349:38-44.
21. Weakley S.M., Wang H., Yao Q., Chen C. Expression and function of a large non-coding RNA gene XIST in human cancer. World J. Surg 2011, 35:1751-1756.
22. Yildirim E., Kirby J.E., Brown D.E., Mercier F.E., Sadreyev R.I., Scadden D.T., et al. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 2013, 152:727-742.
23. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
24. Ma J., Yao Y., Wang P., Liu Y., Zhao L., Li Z., et al. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kruppel-like factor 4. Cancer Lett 2014, 10.1016/j.canlet.2014.09.012.
25. Yao Y., Ma J., Xue Y., Wang P., Li Z., Li Z., et al. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Mol. Oncol 2014, 10.1016/j.molonc.2014.11.003.
26. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell R., et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4:568-580.
27. Karreth F.A., Pandolfi P.P. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov 2013, 3:1113-1121.
28. Li J.H., Liu S., Zhou H., Qu L.H., Yang J.H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014, 42:D92-D97.
29. Yang J.H., Li J.H., Shao P., Zhou H., Chen Y.Q., Qu L.H. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 2011, 39:D202-D209.
30. Jeggari A., Marks D.S., Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 2012, 28:2062-2063.
31. Rehmsmeier M., Steffen P., Hochsmann M., Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517.
32. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640.
33. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
34. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012, 9:703-719.
35. Zhang X., Sun S., Pu J.K., Tsang A.C., Lee D., Man V.O., et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol. Dis 2012, 48:1-8.
36. Zhang X.Q., Leung G.K. Long non-coding RNAs in glioma: functional roles and clinical perspectives. Neurochem. Int 2014, 77:78-85.
37. Li R., Qian J., Wang Y.Y., Zhang J.X., You Y.P. Long noncoding RNA profiles reveal three molecular subtypes in glioma. CNS Neurosci. Ther 2014, 20:339-343.
38. Vawter M.P., Evans S., Choudary P., Tomita H., Meador-Woodruff J., Molnar M., et al. Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 2004, 29:373-384.
39. Wu Z.S., Lee J.H., Kwon J.A., Kim S.H., Han S.H., An J.S., et al. Genetic alterations and chemosensitivity profile in newly established human renal collecting duct carcinoma cell lines. BJU Int 2009, 103:1721-1728.
40. Lassmann S., Weis R., Makowiec F., Roth J., Danciu M., Hopt U., et al. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J. Mol. Med. (Berl.) 2007, 85:293-304.
41. Shi Z., Dragin N., Miller M.L., Stringer K.F., Johansson E., Chen J., et al. Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype. Int. J. Cancer 2010, 127:2334-2350.
42. Nomura S., Baxter T., Yamaguchi H., Leys C., Vartapetian A.B., Fox J.G., et al. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H.felis-infected mice. Gastroenterology 2004, 127:582-594.
43. Kawakami T., Zhang C., Taniguchi T., Kim C.J., Okada Y., Sugihara H., et al. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene 2004, 23:6163-6169.
44. Benoit M.H., Hudson T.J., Maire G., Squire J.A., Arcand S.L., Provencher D., et al. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int. J. Oncol 2007, 30:5-17.
45. Chen Q., Gao S., He W., Kou X., Zhao Y., Wang H., et al. Xist repression shows time-dependent effects on the reprogramming of female somatic cells to induced pluripotent stem cells. Stem Cells 2014, 32:2642-2656.
46. Zhang Z., Zhu Z., Watabe K., Zhang X., Bai C., Xu M., et al. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ 2013, 20:1558-1568.
47. Liu X.H., Sun M., Nie F.Q., Ge Y.B., Zhang E.B., Yin D.D., et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol. Cancer 2014, 13:92.
48. Shi Y., Wang Y., Luan W., Wang P., Tao T., Zhang J., et al. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS ONE 2014, 9. e86295.
49. Qin X., Yao J., Geng P., Fu X., Xue J., Zhang Z. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma. Int. J. Clin. Exp. Pathol 2014, 7:3065-3072.